Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack

被引:67
|
作者
Spiller, OB
Criado-García, O
De Córdoba, SR
Morgan, BP
机构
[1] Univ Wales Coll Med, Dept Biochem Med, Complement Biol Grp, Cardiff CF4 4XX, S Glam, Wales
[2] Fdn Jimenez Diaz, Unidad Patol Mol, E-28040 Madrid, Spain
[3] CSIC, Ctr Invest Biol, Dept Inmunol, Madrid, Spain
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2000年 / 121卷 / 02期
关键词
hepatoma; acute phase; complement regulators; cytokines;
D O I
10.1046/j.1365-2249.2000.01305.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatic parenchymal cells respond in many different ways to acute-phase cytokines. Some responses may protect against damage by liver-derived inflammatory mediators. Previous investigations have shown that cytokines cause increased secretion by hepatoma cells of soluble complement regulatory proteins, perhaps providing protection from complement attack. More important to cell protection are the membrane complement regulators. Here we examine, using flow cytometry and Northern blotting, the effects of different cytokines, singly or in combination, on expression of membrane-bound complement regulators by a hepatoma cell line. The combination of tumour necrosis factor-alpha, IL-1 beta, and IL-6 caused increased expression of CD55 (three-fold) and CD59 (two-fold) and decreased expression of CD46 at day 3 post-exposure. Interferon-gamma reduced expression of CD59 and strongly antagonized the up-regulatory effects on CD59 mediated by the other cytokines. Complement attack on antibody-sensitized hepatoma cells following a 3-day incubation with the optimum combination of acute-phase cytokines revealed increased resistance to complement-mediated lysis and decreased C3b deposition. During the acute-phase response there is an increased hepatic synthesis of the majority of complement effector proteins. Simultaneous up-regulation of expression of CD55 and CD59 may serve to protect hepatocytes from high local concentrations of complement generated during the acute-phase response.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 50 条
  • [21] VIRION ASSOCIATED CD55 AND CD59 CONFER COMPLEMENT RESISTANCE TO HIV-1
    SAIFUDDIN, M
    PARKER, CJ
    PEEPLES, ME
    ZOLLAPAZNER, S
    GHASSEMI, M
    ROONEY, IA
    ATKINSON, JP
    SPEAR, GT
    [J]. FASEB JOURNAL, 1995, 9 (04): : A1048 - A1048
  • [22] Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement
    Hanna, SM
    Spiller, OB
    Linton, SM
    Mead, RJ
    Morgan, BP
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (02) : 502 - 509
  • [23] Quantification of the CD55 and CD59, membrane inhibitors of complement on HIV-1 particles as a function of complement-mediated virolysis
    Nakamura, M
    Okada, H
    Sasaki, H
    Yoshida, K
    Kamada, M
    Okada, N
    Terada, M
    Ohno, T
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1996, 40 (08) : 561 - 567
  • [24] Regulation of complement receptor (CR1 and CR4) and complement regulating molecules (CD55 and CD59) on leukocytes
    Gritti, D
    Muselli, C
    Malinverno, A
    Ricevuti, G
    [J]. MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) : 314 - 314
  • [25] EXPRESSION OF THE COMPLEMENT REGULATORY MOLECULES CD46, CD55 AND CD59 IS REDUCED IN PSORIATIC LESIONS
    VENNEKER, GT
    DAS, PK
    MEINARDI, MMHM
    BOS, JD
    ASGHAR, SS
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 533 - 533
  • [26] THE EXPRESSION OF THE COMPLEMENT REGULATORS CD46, CD55, AND CD59 BY HUMAN SPERM DOES NOT PROTECT THEM FROM ANTISPERM ANTIBODY-MEDIATED AND COMPLEMENT-MEDIATED IMMUNE INJURY
    DCRUZ, OJ
    HAAS, GG
    [J]. FERTILITY AND STERILITY, 1993, 59 (04) : 876 - 884
  • [27] Expression Levels of CD55 and CD59 on Red Blood Cells in Stored Blood
    Al-Humood, S. A. Y. E.
    Al-Faris, L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 209 - 210
  • [28] High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone
    Cowan, PJ
    Shinkel, TA
    Aminian, A
    Romanella, M
    Wigley, PL
    Lonie, AJ
    Nottle, MB
    Pearse, MJ
    d'Apice, AJF
    [J]. XENOTRANSPLANTATION, 1998, 5 (03) : 184 - 190
  • [29] Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59
    Ziller, F
    Macor, P
    Bulla, R
    Sblattero, D
    Marzari, R
    Tedesco, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (07) : 2175 - 2183
  • [30] Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection
    Terpos, Evangelos
    Sarantopoulos, Angelos
    Kouramba, Anna
    Katsarou, Olga
    Stavropoulos, John
    Masouridi, Stavroula
    Karafoulidou, Anastasia
    Meletis, John
    [J]. MEDICAL SCIENCE MONITOR, 2008, 14 (05): : CR276 - CR280